临床肝胆病杂志2017，Vol.33Issue(9)：1617-1620,4.DOI:10.3969/j.issn.1001-5256.2017.09.001
关注重症肝病临床管理的热点问题
Hotspots in clinical management of severe liver diseases
吕佳昱 1韩涛1
作者信息
- 1. 天津市第三中心医院肝内科,天津医科大学第三中心临床学院,天津市人工细胞重点实验室,天津市肝胆疾病研究所,天津300170
- 折叠
摘要
Abstract
Severe liver diseases such as liver failure and acute decompensated cirrhosis have critical conditions and high mortality rates,and the prognosis of such patients is closely associated with early warning,timely dynamic assessment,and comprehensive and effective therapy.The patients require a series of effective clinical management measures for elimination of causative factors,organ support,and prevention and treatment of complications.Medical treatment-artificial liver-liver transplantation is an important modality for severe liver diseases.Granulocyte colony-stimulating factor,stem cell therapy,and bioartificial liver have a promising future,while there are still controversies over non-selective β-blocker.This article reviews the hotspots in the clinical management of severe liver diseases.关键词
肝功能衰竭/肝硬化/肝,人工/肝移植/诊断/治疗/述评Key words
liver failure/liver cirrhosis/liver, artificial/liver transplantation/diagnosis/treatment/editorial分类
医药卫生引用本文复制引用
吕佳昱,韩涛..关注重症肝病临床管理的热点问题[J].临床肝胆病杂志,2017,33(9):1617-1620,4.
